Type 2 Diabetes and Blood Brain Barrier Improvement

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Type2diabetes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UCLA, Los Angeles, California, United States
Contact: Study coordinator (Rajesh Kumar, PHD) · rkumar@mednet.ucla.edu · 310-825-1808
Contact: Study coordinator (Dineth R Karunamuni, MS) · dkarunamuni@mednet.ucla.edu · 856-701-5332
Contact: Principal Investigator (Rajesh Kumar, PHD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ketones, SGLT2, HFrEF

Type2diabetes · Heart Failure With Reduced Ejection Fraction

Abroad (travel likely)RecruitingEARLY_PHASE1

San Antonio, United States

NAD Augmentation in Diabetes Kidney Disease

Type2diabetes · Diabetic Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Boston, United States

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients

Diabetes Mellitus, Type 2 · Diabetes · Type2diabetes

Abroad (travel likely)RecruitingPHASE2

Beijing, China

SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes

Type2diabetes · PreDiabetes · Renal Failure

Abroad (travel likely)RecruitingPHASE4

Berlin, Germany · Dresden, Germany